8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors100 citations

Ding Z, Xiang X, Li J, Wu S

Bioeffects Seen

Authors not listed · 2022

Share:

Cancer cells can hijack DNA repair mechanisms to survive damage, potentially making them more resistant to EMF-induced cellular stress.

Plain English Summary

Summary written for general audiences

Researchers analyzed tumor samples from 232 Chinese patients with clear cell renal cell carcinoma, an aggressive kidney cancer. They identified three cancer subtypes with different metabolic and immune characteristics, discovering that an enzyme called NNMT promotes tumor growth by enhancing DNA repair mechanisms. The study reveals potential new treatment targets for this deadly cancer.

Why This Matters

While this proteogenomic analysis of kidney cancer doesn't directly examine EMF exposure, it provides crucial insights into how cellular repair mechanisms can be hijacked by cancer cells. The finding that NNMT enhances DNA repair through protein modification is particularly relevant to EMF research, since radiofrequency radiation is known to cause DNA damage that cells must repair. When cancer cells become more efficient at repairing DNA damage, they can survive exposures that would normally kill them. This creates a concerning scenario where EMF exposure might not only cause initial DNA damage, but could potentially select for cancer cells that are better at surviving such damage. The identification of metabolic vulnerabilities in aggressive kidney cancers also highlights how EMF-induced cellular stress might interact with existing metabolic dysfunction to accelerate cancer progression.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2022). Ding Z, Xiang X, Li J, Wu S.
Show BibTeX
@article{ding_z_xiang_x_li_j_wu_s_ce2746,
  author = {Unknown},
  title = {Ding Z, Xiang X, Li J, Wu S},
  year = {2022},
  doi = {10.1038/s41467-022-29577-x},
  
}
DOI: 10.1038/s41467-022-29577-xPubMed: 35440542

Quick Questions About This Study

NNMT (Nicotinamide N-methyltransferase) is a metabolic enzyme that the study identified as promoting kidney cancer growth. It modifies DNA repair proteins through a process called homocysteinylation, making cancer cells more efficient at repairing DNA damage and surviving cellular stress.
The proteogenomic analysis classified clear cell renal cell carcinoma into three distinct subtypes (GP1-3). The most aggressive subtype, GP1, showed the strongest immune response, highest metastasis rates, and greatest metabolic imbalance among the 232 patients studied.
Yes, cancer cells with enhanced DNA repair mechanisms can survive treatments that rely on causing DNA damage. The study found that NNMT-driven DNA repair improvements help aggressive kidney cancers resist cellular stress and continue growing, making them harder to treat.
GP1 subtype exhibits the most aggressive characteristics including strongest immune phenotype, increased metastasis potential, and severe metabolic imbalance. These features were linked to worse clinical outcomes, making GP1 the deadliest of the three identified kidney cancer subtypes.
Homocysteinylation is a chemical modification that NNMT causes to DNA-PKcs, a key DNA repair protein. This modification increases the protein's repair efficiency, allowing cancer cells to fix DNA damage more effectively and survive conditions that would normally kill them.